Castellum (CTM) | Q4 2013 | 534,553.47% |
Rezolute (RZLT) | Q1 2013 | 484,329.07% |
Prairie Operating Co Common Stock (PROP) | Q1 2013 | 72,105.65% |
Lipocine (LPCN) | Q4 2013 | 22,608.87% |
Akari Therapeutics (AKTX) | Q4 2013 | 7,000% |
Almonty Industries Inc Common Shares (ALM) | Q2 2013 | 908.03% |
Nutex Health (NUTX) | Q2 2013 | 900% |
AmpliTech (AMPG) | Q2 2013 | 680% |
Tianci International, Inc Common Stock (CIIT) | Q4 2013 | 600% |
VerifyMe (VRME) | Q1 2013 | 577.97% |
INVO Fertility (IVF) | Q4 2013 | 558.54% |
Quantum Computing (QUBT) | Q1 2013 | 466.67% |
ABVC BioPharma (ABVC) | Q1 2013 | 460% |
Enveric Biosciences (ENVB) | Q4 2013 | 385.39% |
BioCryst Pharmaceuticals (BCRX) | Q3 2013 | 366.67% |
GT Biopharma (GTBP) | Q3 2013 | 326.92% |
SUI (SUIG) | Q1 2013 | 313.24% |
TOMI Environmental Solutions (TOMZ) | Q2 2013 | 280% |
Astrotech (ASTC) | Q4 2013 | 277.33% |
Xcel Brands (XELB) | Q1 2013 | 266.67% |
Fonar (FONR) | Q4 2013 | 265.06% |
Armata Pharmaceuticals (ARMP) | Q3 2013 | 240% |
Catalyst Pharmaceuticals (CPRX) | Q3 2013 | 235.16% |
Ryvyl (RVYL) | Q1 2013 | 233.33% |
Scienture (SCNX) | Q3 2013 | 228.57% |
